SCHEMBL21822574

SCHEMBL21822574

O=C(O)C1CC(OCCOc2cc(C(F)(F)F)ccc2-c2cc(=O)c3cccc(Cl)c3o2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 3/20 0.37
▸ S1PR5 Q9H228 3/20 0.37
▸ CCNT1 O60563 2/20 0.36
▸ CDK1 P06493 2/20 0.36
▸ CDK4 P11802 2/20 0.36
▸ CCNB1 P14635 2/20 0.36
▸ CCND1 P24385 2/20 0.36
▸ CDK2 P24941 2/20 0.36
▸ CDK8 P49336 2/20 0.36
▸ CDK9 P50750 2/20 0.36
▸ CDK6 Q00534 2/20 0.36
▸ CDK5 Q00535 2/20 0.36
▸ CCNT2 O60583 1/20 0.36
▸ CYP1A1 P04798 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP1B1 Q16678 2/20 0.35
▸ PDGFRA P16234 2/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ CCNA2 P20248 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25097738 1.00 S1PR1 (0.37) S1PR1S1PR5CCNT1CDK1CDK4
SCHEMBL21822567 0.97 S1PR1 (0.37) S1PR1S1PR5CCNT1CDK1CDK4
SCHEMBL21822520 0.91 CCNT1 (0.36) S1PR1S1PR5CCNT1CDK1CDK4
SCHEMBL25097598 0.90 CCNT1 (0.36) S1PR1S1PR5CCNT1CDK1CDK4
SCHEMBL25097596 0.90 CCNT1 (0.36) S1PR1S1PR5CCNT1CDK1CDK4
SCHEMBL25098031 0.89 SIGMAR1 (0.38) S1PR1CDK1CCNB1CYP1A1CYP1A2
SCHEMBL21822805 0.89 SIGMAR1 (0.38) S1PR1CDK1CCNB1CYP1A1CYP1A2
SCHEMBL25097929 0.89 SIGMAR1 (0.38) S1PR1CDK1CCNB1CYP1A1CYP1A2
SCHEMBL21822545 0.89 SIGMAR1 (0.37) S1PR1CDK1CCNB1CYP1A1CYP1A2
SCHEMBL25097853 0.89 FFAR4 (0.36) S1PR1SIGMAR1CYP3A4FFAR4PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3860984-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. Hoffmann-La Roche AG (CH) 2021-08-11 — — EP claimed
CN-112912371-A Flavone derivatives for treating and preventing hepatitis B virus diseases 豪夫迈·罗氏有限公司 2021-06-04 — — CN claimed
WO-2020070088-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-04-09 — — WO claimed
EP-3860984-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. Hoffmann-La Roche AG (CH) 2021-08-11 — — EP disclosed
CN-112912371-A Flavone derivatives for treating and preventing hepatitis B virus diseases 豪夫迈·罗氏有限公司 2021-06-04 — — CN disclosed
WO-2020070088-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-04-09 — — WO disclosed
Send feedback